News About: Pharm. Industry
KPMA to report unfair trade acts to FTC
The KPMA recalled drug manufacturers on Sept. 4 for a strict compliance to the provision that restrict an unfair trade act such as bribery and cash donations by drug suppliers to medical institutes as specified in "Th...
KPMA called for establishment of Pharmaceutical Industry Fostering Council.
President Kim Jung-soo of the KPMA met with Minister Shin Kook-whan of the MOIE on Sept. 1 and asked for a government positive political support to the pharmaceutical industry by raising an official proposal for estab...
Small company may look at niche market for new management reactivation.
Implementation of the government's new medical reform plan and medical community's prolonged strikes have brought serious business difficulties to the drug industry, especially, medium and small sized companies becaus...
KPMA to promote sales of non-prescription drugs
The KPMA intended to place a large scale of public advertising for the sales increase of general drugs of which any physician's prescriptions are not required, realizing the fact that many people misunderstood the go...
Drug industry in need to keep favorable financial liquidity urgently.
Drug industry faced serious business slow due to ongoing strikes of medical communities and delayed credit payment from customers. Some rumour foretold an Oct. crisis in the drug industry. Under such circumstances man...
Chosun Mookyak bankrupted and struggled to revive
Chosun Mooyak Co. defaulted 3,800 million won payable through 5 local banks, the Seoul, Hana, Shinhan, Hanmi and Pyongwha on Aug. 19 and declared a bankruptcy, but soon tried to revive by selling out the head office b...
B2B infrastructure for drug industry on green light.
The government may support with a full budget allocation for build-up of B2B infra of the electronic commercial transaction business including the drug industry. The Ministry of Planning and Budget announced on Aug. 1...
Domestic medical insurance drug price at 41% level from advanced countries.
According to the survey the KPMA (President Kim Jung-soo) conducted for14,567 products (2,945 different main active substances) on July 27, the medical insurance drug prices showed only 41% level of G7 countries incl...
KPMA demanded for smooth supply of prescription drugs to member companies.
The KPMA urged its member companies to manufacture and supply sufficient stocks of prescriptions drugs for satisfying ever increasing market demands resulted from implementation of the new medical reform program.
T...
Drug industry to provide various promotional plans to customers
By taking an opportunity of pharmaceutical market environmental changes under the medical and pharmacy separation program and the actual purchasing price reimbursement system for all insurance prescription drugs, many...
